Literature DB >> 24575853

The effects of low-level environmental tobacco smoke exposure on pulmonary function tests in preschool children with asthma.

Christina Valsamis1, Sankaran Krishnan, Allen J Dozor.   

Abstract

OBJECTIVES: Though parents of children with asthma smoke, they often avoid smoking in their homes or near their children, thus limiting exposure. It is not known if such low-level environmental tobacco smoke (ETS) results in measurable exposure or affects lung function. The objectives of this study were to measure urinary cotinine in preschool children with asthma, and to examine the relationship between low-level ETS exposure and pulmonary function tests (PFTs).
METHODS: Preschool children with asthma were enrolled. Parents completed questionnaires on ETS exposure and asthma control, urinary cotinine concentrations were measured and PFTs were compared between subjects with and without recent ETS exposure.
RESULTS: Forty one subjects were enrolled. All parents denied smoking in their home within the last 2 weeks, but 14 (34%) parents admitted to smoking outside their homes or away from their children. Fifteen (37%; 95%CI: 23-53) of the children had urinary cotinine levels ≥1 ng/ml, of which seven (17%; 95%CI: 8-32) had levels ≥5 ng/ml. FEV1 and FEV0.5 were lower in subjects with a urinary cotinine level ≥5 ng/ml as compared to those with levels <1 ng/ml or between 1 and 5 ng/ml; both at baseline and after inhalation of albuterol. Five of seven subjects with urinary cotinine levels ≥5 ng/ml had FEV0.5 less than 65% of predicted values. There were no significant differences in IOS measures.
CONCLUSIONS: Despite parental denial of smoking near their children, preschool children may be exposed to ETS. Such low-level ETS exposure may affect lung function, possibly in a dose-dependent manner.

Entities:  

Keywords:  Lung function; preschool children; tobacco smoke exposure

Mesh:

Substances:

Year:  2014        PMID: 24575853     DOI: 10.3109/02770903.2014.894054

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  8 in total

1.  Tobacco Smoke Exposure, Respiratory Health, and Health-care Utilization Among US Adolescents.

Authors:  Ashley L Merianos; Roman A Jandarov; E Melinda Mahabee-Gittens
Journal:  Chest       Date:  2020-04-07       Impact factor: 9.410

2.  Allergic sensitization, rhinitis, and tobacco smoke exposure in U.S. children and adolescents.

Authors:  Josef Shargorodsky; Esther Garcia-Esquinas; Ana Navas-Acien; Sandra Y Lin
Journal:  Int Forum Allergy Rhinol       Date:  2015-04-17       Impact factor: 3.858

3.  Pulmonary effects of active smoking and secondhand smoke exposure among adolescent students in Juárez, Mexico.

Authors:  Yelena Bird; Hugo Staines-Orozco
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-06-29

Review 4.  The Danish National Database for Asthma: establishing clinical quality indicators.

Authors:  Susanne Hansen; Benjamin Hoffmann-Petersen; Asger Sverrild; Elvira V Bräuner; Jesper Lykkegaard; Uffe Bodtger; Lone Agertoft; Lene Korshøj; Vibeke Backer
Journal:  Eur Clin Respir J       Date:  2016-11-08

5.  Behavior of Lung Health Parameters among Smokers and Secondhand Smokers.

Authors:  Esther Ghanem; Re-Mi Hage
Journal:  J Environ Public Health       Date:  2018-03-04

6.  How the Bidi Tobacco Industry Harms Child-workers: Results From a Walk-through and Quantitative Survey.

Authors:  Jihyun Kim; Sohel Rana; Wanhyung Lee; Syed Emdad Haque; Jin-Ha Yoon
Journal:  Saf Health Work       Date:  2020-03-05

Review 7.  The association between environmental tobacco smoke exposure and childhood respiratory disease: a review.

Authors:  A Vanker; R P Gie; H J Zar
Journal:  Expert Rev Respir Med       Date:  2017-06-14       Impact factor: 3.772

8.  Decreased FEV1 % in asthmatic adults in Scottish homes with high Environmental Relative Moldiness Index values.

Authors:  C McSharry; S Vesper; L Wymer; S Howieson; R Chaudhuri; G R Wright; N C Thomson
Journal:  Clin Exp Allergy       Date:  2015-05       Impact factor: 5.018

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.